Still Detox provides medically supervised prescription drug addiction treatment in Boca Raton, Florida. Our board-certified Medical Director manages withdrawal from prescription opioids (oxycodone, hydrocodone, fentanyl), prescription benzodiazepines (Xanax, Ativan, Valium, Klonopin), and prescription stimulants (Adderall, Ritalin, Vyvanse) using individualized clinical protocols in a private, 14-bed setting adjacent to Boca Regional Hospital. Call now for a same-day assessment.
Free & confidential — takes about 60 seconds
Joint Commission Accredited
Florida DCF Licensed
LegitScript Certified
Psychology Today VerifiedPrescription drug addiction occurs when use of a legitimately prescribed medication develops into a pattern meeting DSM-5 criteria for substance use disorder — compulsive use despite significant harm, failed attempts to stop, tolerance, and withdrawal. Physical dependence can develop from medications taken exactly as prescribed. The three prescription drug classes most associated with addiction and clinical withdrawal are opioids, benzodiazepines, and prescription stimulants — each requiring a different clinical approach and carrying different risks if stopped without physician guidance.
The prescription-to-addiction pathway is well-documented. Physical dependence on opioids and benzodiazepines can develop after as few as 4 to 6 weeks of regular use at therapeutic doses — a risk underrecognized by both prescribers and patients. Understanding the difference between physical dependence (a physiological adaptation) and addiction (a behavioral and neurological disorder) matters for clinical planning, but both may require medically supervised treatment to discontinue safely.
Not all prescription drugs require the same level of clinical management when stopping — and this distinction matters enormously. Prescription opioids and benzodiazepines both carry medically serious withdrawal risks. Prescription opioid withdrawal does not typically cause direct death in healthy adults, but the fatal overdose that follows relapse after unsupported detox — when tolerance has dropped — is a leading cause of opioid death. Prescription benzodiazepine withdrawal can produce life-threatening seizures even in individuals using the medication at therapeutic doses for extended periods.
The FDA issued a black box warning on all benzodiazepines in 2020 specifically addressing withdrawal risks. Prescription stimulants such as Adderall do not require a medical taper and do not carry fatal withdrawal risks, but can produce severe depression and suicidal ideation requiring psychiatric monitoring.
At Still Detox, every prescription drug client receives a protocol matched to their specific medication class: COWS-guided management with MAT for opioids, CIWA-guided diazepam substitution for benzodiazepines, and direct monitored stabilization for stimulants. The right protocol depends entirely on the specific prescription.
Prescription drug addiction spans three medically distinct drug classes — each requiring a different clinical protocol. Still Detox treats all three, with the medical infrastructure each demands.
COWS-guided management with MAT for prescription opioids. CIWA-guided diazepam substitution taper for prescription benzodiazepines. Direct monitored stabilization for prescription stimulants. The right protocol is matched to the specific medication.
Buprenorphine induction is available during detox from prescription opioids. Naltrexone (Vivitrol) is available after completion. Per NIDA and the CDC, MAT substantially reduces opioid overdose mortality — including for prescription opioid dependence that began with a legitimate prescription.
Located on the University Hospital campus, adjacent to Boca Regional Hospital. Emergency services are immediately accessible for any client whose prescription benzo or opioid withdrawal requires acute escalation beyond our clinical setting.
Prescription drugs are prescribed for a reason — chronic pain, anxiety, PTSD, ADHD, insomnia. Still Detox treats the underlying condition alongside the dependence using non-addictive evidence-based alternatives so stopping the prescription does not mean returning to unmanaged symptoms.
Prescription drug detox flows directly into inpatient residential treatment on the same campus. The chronic pain management, anxiety treatment, or ADHD management that follows detox is part of the same program — not a separate referral.
Every team member is fluent in English and Spanish. Service animals (dogs and cats) are welcome. Prescription drug addiction treatment is available to all adults regardless of language or companion animal status.
People come to Still Detox when a prescription has become something more. Here is what they say about the care and the recovery they found.
The clinical approach, withdrawal risk level, and protocol differ significantly between prescription drug classes. A physician evaluation on admission is essential before any detox begins.
Prescription opioids produce physical dependence with regular use. Withdrawal begins 8 to 24 hours after the last dose. The primary danger is post-cessation overdose: tolerance drops during detox, making relapse at the previous dose potentially fatal. COWS-guided management and MAT with buprenorphine are the evidence-based standard.
Prescription benzodiazepines carry the most dangerous withdrawal profile of any prescription drug class. Abrupt discontinuation after significant dependence can produce life-threatening seizures even at therapeutic doses. The 2020 FDA black box warning addresses this risk directly. CIWA-guided diazepam substitution taper is the clinical standard at Still Detox.
Prescription stimulants do not require a medical taper and do not carry seizure or cardiovascular collapse risk during cessation. Clients are admitted directly into monitored stabilization. The primary challenges are psychological: stimulant crash depression, suicidal ideation, prolonged PAWS, and the ADHD that typically underlies the prescription.
Here is how prescription drug addiction treatment works from first call through residential care — matched to your specific medication class.
Admissions gathers your specific prescription, current dose, duration of use, and co-occurring conditions (chronic pain, anxiety, ADHD). PPO benefits verified before you commit. Travel coordinated before arrival.
A call within three days covers your complete medication and psychiatric history — so the appropriate protocol (COWS/MAT for opioids, CIWA taper for benzos, direct stabilization for stimulants) is ready on day one.
A nurse and behavioral health tech handle intake together. Urine toxicology confirms substances. Clinical assessment begins immediately and appropriate medications are available from the first hours of admission.
Within 24 hours the Medical Director completes a full history and physical. The individualized taper schedule or stabilization plan is established based on your specific prescription, dose, duration of use, and clinical history.
Withdrawal severity assessments drive daily medication adjustments. Buprenorphine manages opioid cravings. Diazepam taper proceeds on the individualized benzo schedule. Comfort medications address stimulant crash. Typical stay is 7 to 14 days by drug class.
You step directly into residential treatment on the same campus — same team, same setting. The chronic pain, anxiety, or ADHD underlying the prescription is addressed with non-addictive evidence-based alternatives in the program that follows.
The DSM-5 applies 11 diagnostic criteria across all substance use disorders. Any 2 or more in a 12-month period constitutes a diagnosis. A key clinical nuance: tolerance and withdrawal alone (criteria 10 and 11) do not constitute addiction if the patient is using the medication as prescribed — additional criteria of compulsive use and harm are required.
Taking medication in larger doses, more frequently, or for longer than prescribed. In prescription opioid dependence, this often begins as legitimate pain management before dose escalation outpaces the prescription as tolerance develops.
A persistent desire to taper or stop combined with repeated unsuccessful attempts. Withdrawal symptoms from opioids and benzodiazepines make self-directed discontinuation extremely difficult — and for benzodiazepines, potentially fatal without medical supervision.
Doctor shopping, early refill requests, or significant time managing supply. When obtaining the medication begins to consume significant planning and energy, it signals advancing disorder severity beyond legitimate medical need.
A powerful urge to take the medication, particularly when a dose is delayed or withdrawal onset is anticipated. In opioid and benzo dependence, craving is often the nervous system signaling the approach of withdrawal rather than the pursuit of euphoria.
Sedating effects of prescription opioids or benzodiazepines, or the crash from prescription stimulants, interfering with work, family responsibilities, or daily obligations beyond what the underlying condition would produce unmedicated.
Persisting with prescription drug use despite conflict with family or partners — emotional withdrawal from opioids and benzos, erratic behavior from stimulant use patterns, or dishonesty around supply creating sustained relationship damage.
Giving up hobbies, social engagement, or valued pursuits as prescription drug use progressively narrows life's scope — particularly with opioid or benzodiazepine dependence where the sedating cycle can displace most prior interests and relationships.
Driving while on sedating doses of opioids or benzodiazepines; combining prescription opioids with benzodiazepines or alcohol (the FDA black box warning on opioids specifically flags this combination); or taking prescription stimulants at doses far beyond prescribed levels.
Persisting despite awareness of consequences — cognitive impairment from long-term benzodiazepines, opioid-induced hyperalgesia, cardiovascular effects from stimulants, or documented worsening of the original condition the prescription was meant to treat.
Requiring higher doses to achieve the same effect, or finding that the prescribed dose no longer provides adequate relief. Tolerance in opioid and benzo prescriptions indicates advancing physical dependence and signals that discontinuation requires clinical supervision.
Experiencing physical symptoms when the prescription is delayed — muscle pain and nausea for opioids; anxiety, tremors, and elevated heart rate for benzodiazepines; depression and fatigue for stimulants. The presence of withdrawal confirms physical dependence and the need for medically supervised discontinuation.
DSM-5 substance use disorder criteria. Tolerance and withdrawal from a prescription alone do not constitute addiction — but both signal that medical supervision is required before stopping. Call now.
Talk to Admissions ConfidentiallyThese are real before-and-after moments from people who completed treatment at Still Detox — people whose prescription became a dependency, and whose recovery began with one call.
Prescription benzodiazepine withdrawal seizures are documented in individuals using benzos at therapeutic doses for extended periods. The 2020 FDA black box warning on all benzodiazepines addresses this risk directly. Anyone taking a prescribed benzodiazepine regularly should consult a physician before attempting to stop — the appropriate taper rate cannot be safely self-directed.
Opioid tolerance drops rapidly during even brief abstinence. Someone who stops prescription opioids for a week and relapses at their previous dose is no longer tolerant to that dose and faces dramatically elevated fatal overdose risk. MAT with buprenorphine substantially reduces this post-cessation risk.
Stopping oxycodone does not resolve chronic pain. Stopping Xanax does not resolve panic disorder. Stopping Adderall does not resolve ADHD. Treatment that addresses only the dependence without the underlying condition means those symptoms return in full force — creating immediate pressure to resume the prescription.
Still Detox is an out-of-network provider for most insurance plans. Many clients with PPO plans apply out-of-network benefits toward prescription drug detox and residential treatment. Our admissions team verifies your specific benefits at no cost and with no obligation before admission.
We confirm what your plan covers, walk through any out-of-pocket responsibility, and explain flexible payment options including monthly payment plans. The transition from a prescription that started legitimately to treatment that begins recovery should never be blocked by cost.
Don't see your plan? Call us. Our specialists work with many coverage scenarios and will give you an honest answer about what is covered.
Prescription drug withdrawal spans a wide clinical spectrum. Our facility is designed to support recovery across opioid bone pain, benzo-related anxiety and sensory hypersensitivity, and stimulant crash depression alike.
Many clients develop opioid dependence through legitimate chronic pain treatment. Still Detox manages opioid detox alongside non-opioid pain management planning — so stopping opioids does not mean returning to uncontrolled pain. See our full opioid addiction treatment page.
Benzodiazepines are most commonly prescribed for anxiety. Still Detox treats the physical benzo dependence and the underlying anxiety disorder concurrently using non-benzodiazepine alternatives. See our full benzodiazepine addiction treatment page.
Prescription stimulant dependence frequently co-occurs with the ADHD it was prescribed to treat. Still Detox's residential program addresses ADHD management using non-stimulant alternatives. See our full Adderall addiction treatment page.
Prescription drug dependence that began with legitimate medical need deserves a clinical response that addresses both the dependence and the underlying condition. Our team is on-site 24 hours a day, same-day assessments are available, and residential care that treats the root cause begins right after stabilization.
We're here 24/7. Speak with admissions, confidentially and with no obligation.
✆ Call (561) 556-2677Accreditations & Memberships
We understand that there are no shortcuts on the path to recovery, and our compassionate team offers unwavering support and intensive care throughout your healing journey.
Still Detox is a member of Still Behavioral Health Group.
Get Help Now
If you or someone you care about is seeking support for substance abuse and addiction challenges, we are here to offer our assistance. This is where your journey towards healing begins.
© 2026 | Still Detox Drug and Alcohol Treatment Center in Florida
950 NW 9th CT, Boca Raton, FL 33486
